Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - March 2009

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for March 2009 (PDF).

This issue contains a hot topic about the public perception of herbal medicines, a yellow card update that focusses on the rare adverse drug reaction of progressive multifocal leukoencephalopathy (PML) and drug safety updates in the following areas:

  • Methylphenidate: updated guidance on safe and effective use in ADHD
  • Atomoxetine: risk of psychotic or manic symptoms
  • Antipsychotics: use in elderly patients with dementia
  • Exenatide (Byetta): risk of severe pancreatitis and renal failure
  • Bisphosphonates: atypical stress fractures

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - March 2009' on Email Share 'Drug Safety Update - March 2009' on Delicious Share 'Drug Safety Update - March 2009' on Digg Share 'Drug Safety Update - March 2009' on Facebook Share 'Drug Safety Update - March 2009' on Google+ Share 'Drug Safety Update - March 2009' on reddit Share 'Drug Safety Update - March 2009' on StumbleUpon Share 'Drug Safety Update - March 2009' on Twitter

atomic-wealth

One Comments to “Drug Safety Update - March 2009”

  1. [...] and diaphyseal femur fractures). The Medicines and Healthcare products Regulatory Agency reviewed the risk of atypical stress fractures with alendronate in the March 2009 issue of Drug Safety [...]

    Pingback by Prescribing Advice For GPs » Bisphosphonates And Fracture Risk — October 19, 2010 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,524 spam comments.

atomic-wealth
fond-illness
summer